Page last updated: 2024-08-25

chitosan and Chronic Primary Open Angle Glaucoma

chitosan has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Castilho, RO; Cesar, ALA; Cronemberger, S; Ferreira, AJ; Foureaux, G; Gomes Faraco, AA; Goulart, GAC; Navarro, LC1
Alharbi, KS; Alruwaili, NK; Alsaidan, OA; Alshehri, S; Ansari, MJ; Elmowafy, M; Imam, SS; Salahuddin, M; Yasir, M; Zafar, A1

Other Studies

2 other study(ies) available for chitosan and Chronic Primary Open Angle Glaucoma

ArticleYear
New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study.
    Journal of biomedical materials research. Part A, 2021, Volume: 109, Issue:3

    Topics: Animals; Antiglaucoma Agents; Chitosan; Chondroitin Sulfates; Delayed-Action Preparations; Diminazene; Drug Liberation; Glaucoma, Open-Angle; Male; Rats; Rats, Wistar

2021
Formulation of carteolol chitosomes for ocular delivery: formulation optimization,
    Cutaneous and ocular toxicology, 2021, Volume: 40, Issue:4

    Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Animals; Carteolol; Chitosan; Cornea; Drug Liberation; Glaucoma, Open-Angle; Goats; Humans; Liposomes; Time Factors

2021